Correction of Coagulation in Dilutional Coagulopathy: Use of Kinetic and Capacitive Coagulation Assays to Improve Hemostasis

Transfusion Medicine Reviews

Volumn 24, Issue 1, 2010, Pages 44-52

  Schols, Saskia E M ^a,b   Heemskerk, Johan W M ^a,b   van Pampus, Elisabeth C M ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CALCIUM CHLORIDE; DESMOPRESSIN; FIBRIN; FIBRINOGEN; FRESH FROZEN PLASMA; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TRANEXAMIC ACID;

ARTICLE; BIOASSAY; BIOCHEMISTRY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CLINICAL PROTOCOL; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; DISEASE MANAGEMENT; HEMOSTASIS; HUMANS;

EID: 70749088102     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2009.09.004     Document Type: Article

References (73)

1. Levy J.H. Massive transfusion coagulopathy. Semin Hematol 43 (2006) S59-S63
2. Stainsby D., MacLennan S., Thomas D., et al. Guidelines on the management of massive blood loss. Br J Haematol 135 (2006) 634-641
3. Hellstern P., Muntean W., Schramm W., et al. Practical guidelines for the clinical use of plasma. Thromb Res 107 (2002) S53-S57
4. Hellstern P., and Haubelt H. Indications for plasma in massive transfusion. Thromb Res 107 (2002) S19-S22
5. Hardy J.F., de Moerloose P., and Samama C.M. Massive transfusion and coagulopathy: Pathophysiology and implications for clinical management. Can J Anaesth 53 (2006) S40-S58
6. Hardy J.F., de Moerloose P., and Samama C.M. The coagulopathy of massive transfusion. Vox Sang 89 (2005) 123-127
7. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 73 (2007) 401-415
8. American-Society-of-Anesthesiologists. Practice guidelines for blood component therapy. Anesthesiology 84 (1996) 732-747
9. Samama C.M., Djoudi R., Lecompte T., et al. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003. Minerva Anestesiol 72 (2006) 447-452
10. Heindl B., and Biberthaler P. Coagulation management of severe surgical bleeding. Unfallchirurg 111 (2008) 574-583
11. Erber W.N. Massive blood transfusion in the elective surgical setting. Transfus Apher Sci 27 (2002) 83-92
12. Gaarder C., Naess P.A., Frischknecht Christensen E., et al. Scandinavian Guidelines-The massively bleeding patient. Scand J Surg 97 (2008) 15-36
13. Spahn D.R., Cerny V., Coats T.J., et al. Management of bleeding following major trauma: A European guideline. Crit Care 11 (2007) R17
14. Mitra B., Mori A., Cameron P.A., et al. Massive blood transfusion and trauma resuscitation. Injury 38 (2007) 1023-1029
15. Malone D.L., Hess J.R., Fingerhut A., et al. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 60 (2006) S91-S96
16. O'Keeffe T., Refaai M., Tchorz K., et al. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 143 (2008) 686-690
17. Ketchum L., Hess J.R., and Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 60 (2006) S51-S58
18. Spivey M., and Parr M.J. Therapeutic approaches in trauma-induced coagulopathy. Minerva Anestesiol 71 (2005) 281-289
19. Perkins J.G., Cap A.P., Weiss B.M., et al. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med 36 (2008) S325-S339
20. Busani S., Cavazzuti I., Marietta M., et al. Strategies to control massive abdominal bleeding. Transplant Proc 40 (2008) 1212-1215
21. Grottke O., Henzler D., and Rossaint R. Use of blood and blood products in trauma. Best Pract Res Clin Anaesthesiol 21 (2007) 257-270
22. Hakala P., Hiippala S., Syrjala M., et al. Massive blood transfusion exceeding 50 units of plasma poor red cells or whole blood: The survival rate and the occurrence of leukopenia and acidosis. Injury 30 (1999) 619-622
23. Kashuk J.L., Moore E.E., Johnson J.L., et al. Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma:packed red blood cells the answer?. J Trauma 65 (2008) 261-270
24. Spinella P.C. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 36 (2008) S340-S345
25. Schreiber M.A., Perkins J., Kiraly L., et al. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 205 (2007) 541-545
26. Hess J.R., and Holcomb J.B. Transfusion practice in military trauma. Transfus Med 18 (2008) 143-150
27. Singbartl K., Innerhofer P., Radvan J., et al. Hemostasis and hemodilution: A quantitative mathematical guide for clinical practice. Anesth Analg 96 (2003) 929-935
28. Karlsson M., Ternstrom L., Hyllner M., et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: A prospective observational study. Transfusion 48 (2008) 2152-2158
29. Mangus R.S., Kinsella S.B., Nobari M.M., et al. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique. Transplant Proc 39 (2007) 3207-3213
30. Valeri C.R., Ragno G., Pivacek L.E., et al. A multicenter study of in vitro and in vivo values in human RBCs frozen with 40-percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4 degrees C in AS-3: Assessment of RBC processing in the ACP 215. Transfusion 41 (2001) 933-939
31. Hirshberg A., Dugas M., Banez E.I., et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: A computer simulation. J Trauma 54 (2003) 454-463
32. Moore F.A., Nelson T., McKinley B.A., et al. Is there a role for aggressive use of fresh frozen plasma in massive transfusion of civilian trauma patients?. Am J Surg 196 (2008) 948-958
33. Scalea T.M., Bochicchio K.M., Lumpkins K., et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 248 (2008) 578-584
34. Stinger H.K., Spinella P.C., Perkins J.G., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 64 (2008) S79-S85
35. Despotis G., Eby C., and Lublin D.M. A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion 48 (2008) 2S-30S
36. Hemker H.C., Al Dieri R., De Smedt E., et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96 (2006) 553-561
37. Vanschoonbeek K., Feijge M.A., Van Kampen R.J., et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: Subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2 (2004) 476-484
38. Haas T., Fries D., Velik-Salchner C., et al. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 106 (2008) 1360-1365
39. Schols S.E., Feijge M.A., Lance M.D., et al. Effects of plasma dilution on tissue factor-induced thrombin generation and thromboelastography: Partly compensating role of platelets. Transfusion (2008) 2384-2394
40. Tanaka K.A., Taketomi T., Szlam F., et al. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 106 (2008) 732-738
41. Ganter M.T., Schmuck S., Hamiel C.R., et al. Monitoring recombinant factor VIIa treatment: Efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy. J Cardiothorac Vasc Anesth 22 (2008) 675-680
42. Johansson P.I., Jacobsen N., Viuff D., et al. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers. Br J Haematol 143 (2008) 559-569
43. De Lorenzo C., Calatzis A., Welsch U., et al. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 102 (2006) 1194-1200
44. Johansson P.I. Off-label use of recombinant factor VIIa for treatment of haemorrhage: Results from randomized clinical trials. Vox Sang 95 (2008) 1-7
45. Goodnough L.T., and Shander A.S. Recombinant factor VIIa: Safety and efficacy. Curr Opin Hematol 14 (2007) 504-509
46. Karkouti K., Beattie W.S., Arellano R., et al. Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 118 (2008) 331-338
47. MacLaren R., Weber L.A., Brake H., et al. A multicenter assessment of recombinant factor VIIa off-label usage: Clinical experiences and associated outcomes. Transfusion 45 (2005) 1434-1442
48. Masud F., Bostan F., Chi E., et al. Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: A retrospective analysis of dosing, efficacy, and safety outcomes. J Cardiothorac Vasc Anesth (2008) 28-33
49. Reinhofer M., Brauer M., Franke U., et al. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 19 (2008) 212-219
50. Mengistu A.M., Wolf M.W., Boldt J., et al. Evaluation of a new platelet function analyzer in cardiac surgery: A comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth 22 (2008) 40-46
51. Schols S.E., van der Meijden P.E., van Oerle R., et al. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleeding. Thromb Haemost 99 (2008) 64-70
52. Cammerer U., Dietrich W., Rampf T., et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96 (2003) 51-57
53. Rizoli S.B., Boffard K.D., Riou B., et al. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: Subgroup analysis from two randomized trials. Crit Care 10 (2006) R178
54. Zaaroor M., Soustiel J.F., Brenner B., et al. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy. Acta Neurochir (Wien) 150 (2008) 663-668
55. Stein D.M., Dutton R.P., Hess J.R., et al. Low-dose recombinant factor VIIa for trauma patients with coagulopathy. Injury 39 (2008) 1054-1061
56. Bruce D., and Nokes T.J. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: Experience in a large tertiary hospital. Crit Care 12 (2008) R105
57. Pabinger I., Brenner B., Kalina U., et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: A prospective multinational clinical trial. J Thromb Haemost 6 (2008) 622-631
58. Yasaka M., Sakata T., Naritomi H., et al. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 115 (2005) 455-459
59. Mittermayr M., Streif W., Haas T., et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration. Anesth Analg 105 (2007) 905-917
60. Weinkove R., and Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 18 (2008) 151-157
61. Fenger-Eriksen C., Midtgaard J.T., Kristensen B.S., et al. Fibrinogen substitution improves whole blood clot firmness following dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy-A randomised placebo-controlled clinical trial. J Thromb Haemost 7 (2009) 795-802
62. Danes A.F., Cuenca L.G., Bueno S.R., et al. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 94 (2008) 221-226
63. Fishman P.E., Drumheller B.C., Dubon M.E., et al. Recombinant activated factor VII use in the emergency department. Emerg Med J 25 (2008) 625-630
64. Lusher J.M., Roberts H.R., Davignon G., et al. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group. Haemophilia 4 (1998) 790-798
65. Hardy J.F., Belisle S., and Van der Linden P. Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: A review of 17 randomized controlled trials. Ann Thorac Surg 86 (2008) 1038-1048
66. Moltzan C.J., Anderson D.A., Callum J., et al. The evidence for the use of recombinant factor VIIa in massive bleeding: Development of a transfusion policy framework. Transfus Med 18 (2008) 112-120
67. Samama C.M. Prothrombin complex concentrates: A brief review. Eur J Anaesthesiol 25 (2008) 784-789
68. Haas T., Fries D., Velik-Salchner C., et al. Fibrinogen in craniosynostosis surgery. Anesth Analg 106 (2008) 725-731
69. Weisel J.W. Structure of fibrin: Impact on clot stability. J Thromb Haemost 5 (2007) S116-S124
70. van Veen J.J., Gatt A., and Makris M. Thrombin generation testing in routine clinical practice: Are we there yet?. Br J Haematol 142 (2008) 889-903
71. Ganter M.T., and Hofer C.K. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106 (2008) 1366-1375
72. Rugeri L., Levrat A., David J.S., et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 5 (2007) 289-295
73. Spalding G.J., Hartrumpf M., Sierig T., et al. Cost reduction of perioperative coagulation management in cardiac surgery: Value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg 31 (2007) 1052-1057